Health Care & Life Sciences » Pharmaceuticals | Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is December-November. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,415
1,468
1,594
1,397
1,458
1,120
Depreciation, Depletion & Amortization
2,111
1,909
1,964
2,238
2,525
2,823
Other Funds
1,962
2,086
1,058
2,157
1,786
1,728
Funds from Operations
5,488
5,464
2,500
5,791
5,770
5,671
Changes in Working Capital
2,463
1,993
5,348
8,538
7,751
2,838
Net Operating Cash Flow
7,951
3,470
2,848
2,747
1,981
2,833
Capital Expenditures
2,264
1,248
2,485
3,680
3,103
Sale of Fixed Assets & Businesses
157
145
768
-
-
Purchase/Sale of Investments
785
775
3,366
1,021
5,265
Net Investing Cash Flow
713
784
5,083
2,755
2,578
Cash Dividends Paid - Total
882
997
1,056
1,158
1,146
Issuance/Reduction of Debt, Net
8,536
1,986
2,236
5,936
2,517
Net Financing Cash Flow
9,418
2,983
4,550
3,714
985
Net Change in Cash
2,180
297
3,381
1,788
388
Free Cash Flow
5,710
2,262
5,315
4,867
4,255
Other Sources
609
-
-
454
651
Change in Capital Stock
-
-
3,370
1,064
2,356
Other Uses
-
456
-
550
235

About Hyundai Pharmaceutical Co.

View Profile
Address
55 Jandari-gil
Cheonan SC 31213
Korea, Republic Of
Employees -
Website http://www.hyundaipharm.co.kr
Updated 07/08/2019
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.